Royalty Report: Medical, Device, Surgical – Collection: 1190

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 17

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 17

Primary Industries

  • Medical
  • Device
  • Surgical
  • Supply
  • Technical Know How
  • Diagnostic
  • Test/Monitoring
  • Ultrasound
  • Software
  • Educational
  • Medical Info
  • Mobile

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1190

License Grant
The Licensee entered into a patent License Agreement, to License certain intellectual property from a third party to be used in the Licensee's products.
Field of Use
The Licensee designs, manufactures and markets a family of computer-assisted, power-actuated endomechanical surgical instruments, referred to as Intelligent Surgical Instrumentsâ„¢, used for cutting, stapling and tissue manipulation in a variety of procedures in open surgery, minimally invasive surgery, or MIS, and in the emerging field of natural orifice translumenal endoscopic surgery.

IPSCIO Record ID: 28044

License Grant
The Licensor has an Agreement with the Licensee, which represents the development of an ultrasonic sergical device, and as a result of that joint development; patents are co-owned by both parties.
License Property
The Licensor designs, manufactures, develops and markets minimally invasive ultrasonic surgical device products.

Technology relates to laparoscopic products, which uses high frequency sound waves to coagulate and divide tissue for both open and laparoscopic surgery.

Field of Use
The AutoSonix ultrasound cutting and coagulating system is distributed and marketed for the Licensor through an agreement with the Licensee.

IPSCIO Record ID: 29212

License Grant
The Licensee entered into an exclusive License and development Agreement with an Australian University, granting the Company a worldwide exclusive (even as to the university) License, with rights to subLicense, to all the Company’s product candidates and associated know-how based on the University's technology, including the exclusive right to manufacture, use and sell the product candidates. The Company agreed to invest towards development of any Licensed product.
License Property
The University Intellectual Resources Management is focused on developing the key surgical devices that would make noninvasive procedures a reality.  The Licensee is a developmental stage medical device company focused on the development of medical devices that manipulate tissues for endoscopic and minimally invasive surgery for the treatment of obesity, gastroesophageal reflux disease, Barrett's Esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation and other intraperitoneal abnormalities.  The Company’s product portfolio includes a device for endoscopic bariatric surgery (obesity surgery) and endoscopic repair of gastroesophageal reflux disorder (GERD), as well as an endoscopic device for excision and diagnosis of Barrett’s esophagus.

Licensed Patent Rights and Licensed Patents shall mean (1) United States Provisional Patent Application No. 60/698,748 filed July 13, 2005, and titled Suturing System for Transoral Gastroplasty and United States Provisional Patent Application No. 60/742,826 filed December 6, 2005, and titled Systems and Techniques for Transoral Gastroplasty; (2) International Patent Application No. PCT/US04/028516 entitled Suturing Devices and Methods, filed September 2, 2004 (claiming benefit of U.S. Provisional Patent Application Serial No. 60/499,539, filed September 2, 2003; U.S. Provisional Patent Application Serial No. 60/507,837, filed October 1, 2003; and U.S. Provisional Patent Application Serial No. 60/576,510, filed June 3, 2004); (3) any and all Patent Rights under the patents or patent applications for any Additional Technologies and associated Know-How licensed by the Company.

IPSCIO Record ID: 317633

License Grant
The Company and an executive of the Company entered into a Royalty Agreement wherein the Company agreed to pay the executive a royalty on a product-by-product basis for certain proprietary information and inventions that were patented during his employment with the Company.
License Property
Proprietary information and inventions include but not limited to the products such as Lucent Lateral Interbody Implant System, the Lucent XP Expandable Interbody Device System, the Clutch ISP Posterior Fixation System, the Karma Fixation System, the Vertu Anterior Stand-Alone System and Mosaic devices.

The product portfolio addresses a broad spectrum of spine surgery procedures and consists of innovative spinal fixation systems (implantable hardware systems that are mechanically attached to the spine and provide stability), interbody implants (devices implanted between the vertebral bodies of the spine), surgical instruments (instruments used to prepare the spine and implant our devices) and biologics (allograft or synthetic biomaterials intended to augment or replace the normal capacity of such tissue in the body).

“Product Line” shall mean each of the following product categories, with each understood to specifically contain and be solely composed of the individual products and parts set forth on Schedule A (i) Mosaic, (ii) Vertu, (iii) Lucent Lateral, (iv) Lucent Expandable, (v) ISP (Clutch), and (vi) Zip Tie (Karma).

Field of Use
The field of use is for the procedures used in surgery with reduced trauma to the muscles and soft tissues, less blood loss, smaller incisions, shorter procedure time, reduced hospitalization, lower post-operative medication use, faster patient recovery and other benefits for patients and surgeons.

The Company is a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MIS”) procedures.

IPSCIO Record ID: 1218

License Grant
The Company settled this matter through granting a nonexclusive worldwide license of its argon beam coagulation technology.
License Property
Argon Beam Coagulation (ABC) is a special method of electrosurgery, which allows a faster and more complete coagulation of many tissues as compared to conventional electrosurgery. Unlike conventional electrosurgery, the current travels in a beam of ionized argon gas, allowing the current to be dispersed onto the bleeding tissue without the instrument touching the tissue. Clinicians have reported notable benefits of ABC in certain clinical situations including open-heart surgery, liver, spleen and trauma surgery and various other applications.  Electrosurgery is the technique of using a high-frequency electric current which, when applied to tissue through special instruments, can be used to cut tissue, coagulate, or cut and coagulate simultaneously. An electrosurgical system consists of a generator, an active electrode in the form of a pencil or other instrument which the surgeon uses to apply the current from the generator to the target tissue and a ground pad to safely return the current to the generator. Electrosurgery is routinely used in most forms of surgery, including dermatologic and thoracic, orthopedic, urologic, neurosurgical, gynecological, laparoscopic and other endoscopic procedures.

IPSCIO Record ID: 1667

License Grant
The Company has acquired rights to a significant number of patents from an undisclosed third parties, including rights that apply to the Company’s current balloon dissection systems; related surgical instruments for use in minimally invasive surgery.

IPSCIO Record ID: 66891

License Grant
The Licensee entered into a Patent Assignment and Licensing Agreement with an undisclosed third party which was later amended in November 2012.
License Property
The patented technology is used in the AirSeal products. As part of the Licensing Agreement, proprietary patents and patent applications were sold, assigned and transferred to the Licensee so that the Licensee could develop and commercialize products in the AirSeal® System optimizing the laparoscopic environment and providing stability in the abdominal cavity during minimally invasive surgery.  AirSeal is a proprietary surgical access management system, which offers significant clinical benefits for patients and economic benefits for healthcare providers.
Field of Use
The Licensee is a commercial stage global medical technology company marketing a device used in Minimally Invasive Surgery.

IPSCIO Record ID: 1098

License Grant
Licensor grants Licensee a non-exclusive, world-wide license under the Licensed Patents to the Licensed Devices for Licensed Applications which would infringe any valid claim of the Licensed Patents.
License Property
Licensor is the owner of U.S. Patent No. 5,037,421 and U.S. Patent No. 5,147,354 both entitled 'Mid Infrared Laser Arthroscopic Procedure'.

LICENSED DELIVERY DEVICE shall mean any device that delivers the laser energy to a desired location which infringes one or more of the valid claims of the Licensed Patents.

Field of Use
LICENSED APPLICATION shall mean only orthopedic applications.

IPSCIO Record ID: 203978

License Grant
The Canadian Licensor grants to Licensee an exclusive, worldwide license, with the right to grant and authorize sublicenses, to Licensors entire interest in and to the Licensed Patents within the Field to make, have made, use, import, have imported, sell, offer for sale and otherwise exploit and distribute Licensed Products within the Field, and practice any method, process or procedure included within the Licensed Patents in the Field.
License Property
The licensed patents are for Two-Dimensional and Three-Dimensional Digital Ultrasound Tracking Systems for surgery.  The Licensed Product means a product within the scope of one or more Valid Claims of the Licensed Patents in the country of manufacture or sale;  produced, processed or otherwise manufactured by a process or method within the scope of one or more Valid Claims of the Licensed Patents in the country of such manufacture; or; used in a process and/or method within the scope of one or more Valid Claims of the Licensed Patents in the country where such product is made or sold.
Field of Use
The Field shall mean use of any medical device and procedure applications in and on the heart that utilize essentially real-time triangulation algorithms to determine the three-dimensional position of transducers, excluding procedures solely and directly related to heart valve surgery.

IPSCIO Record ID: 26718

License Grant
The Patent Owner, an individual, granted the Licensee a license under the Licensed Patent to make, use, and sell Licensed Products for use in the Licensed Field of Use within the Licensed Territory.
License Property
Licensed Products means any water jet device for use in the medical, surgical and dental fields (the Licensed Field of Use).

Applicant's invention relates to instruments and tools useful for incising biologic tissues.

U.S. Patent #5,620,414 titled 'Apparatus and Method for Effecting Surgical Incision Through Use of a Fluid Jet' filed on April 8, 1994 and issued on April 15, 1997 (CIP of U.S. Serial Number 906,558, filed June 30, 1992 — abandoned).

Field of Use
'Licensed Field of Use' means those disciplines or areas of endeavor into and for which LICENSEE may sell Licensed Products, and includes the medical, surgical and dental fields.

IPSCIO Record ID: 473

License Grant
Licensor, an individual, agrees to provide twelve consulting days per 12 month Period. Consulting Services will address the clinical use of BioGlue in cardiac and vascular surgery, either in open surgery or minimally invasive surgery, the development of catheter(s) and related products to facilitate the use of BioGlue in these clinical applications, the presentation of clinical information at surgical meetings, educational symposia and other surgical congresses for the purpose of surgeon education and training and the clinical use of SynerGraft heart valves, O’Brien heart valves, CryoGraft-SG and CryoValve-SG.

IPSCIO Record ID: 4763

License Grant
The Company hereby grants the exclusive worldwide license within the Field under IXION Patents (4,490,810 & 4,907,973) and Technology to make, have made, use, lease, and sell or otherwise dispose of royalty bearing products.
License Property
The patented technology is an endoscopic surgery simulator for use by surgeons and trainees and owns rights to patents regarding such simulators.
Field of Use
Field or technical field shall mean methods, processes, devices, and instruments for the simulation of endoscopic and minimally invasive surgery in humans through an extendable, multi-plane computer-based video laparoscopic surgical training apparatus with tactile feedback for the teaching of surgical skills.

IPSCIO Record ID: 27345

License Grant
The Company has been granted three United States patents relating to the use of tissue on a removable backing which cover the sleeve configuration of Peri- Strips, the combination of tissue with a surgical stapling gun, and methods of performing a surgical procedure to remove diseased tissue.
License Property
Patent relates to Peri-Strips Dry covering the application of buttressing material (tissue or other synthetic material) onto a surgical stapler for purposes of reinforcing a surgical fastener suture line utilizing an adhesive substance and a positional and pressure equalization device to accomplish the adherence of the tissue to the surgical suturing device.

IPSCIO Record ID: 4346

License Grant
An Irish leading global provider of healthcare products, today announced that it has won a court decision ruling of patent infringement against a company with a Harmonic line of ultrasonic surgical products.
License Property
The federal court found that US Patents 6,063,050, 6,468,286, and 6,682,544, each relating to ultrasonic cutting and coagulation surgical devices were infringed.
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 2170

License Grant
The Company signed a Patent License, Research & Development Agreement in which the Company licensed  the world-wide manufacturing and distribution rights to the spinal dissector.
License Property
The Spinal Dissector is patented minimally invasive devices for use in spinal surgery, which have been evaluated in vivo.

IPSCIO Record ID: 3489

License Grant
The Company announced today that it received a ruling from the U.S. District Court in regards to ongoing royalty rates for Phase I of its patent litigation with Plaintiff. As previously announced, Phase 2 surrounding the cervical plates involved in the dispute was settled.
License Property
On August 17, 2012, Plaintiff filed additional patent claims in the U.S. District Court for the Northern District of Indiana alleging that the Company various spinal implants (including its CoRoent® XL family of spinal implants) infringe U.S. Patent No. 8,021,430, and that the Company's Osteocel® Plus bone graft product infringes U.S. Patent No. 5,676,146 C2. On August 28, 2012, Plaintiff amended its complaint in the Northern District of Indiana alleging that NuVasive's XLIF® procedure and use of MaXcess IV retractor during the XLIF procedure infringe methodology claims of U.S. Patent No. 8,251,997.
Field of Use
The CoRoent XL is a family of spinal implants used to replace weakened or damaged intervertebral discs. These discs act as the spine’s shock absorber allowing forces to be distributed evenly during the body’s movements.

And MaXcess instruments provide access to the spine in a manner that affords direct visualization and our nerve monitoring systems assist surgeons in avoiding critical nerves.  Our MaXcess system consists of instrumentation and specialized implants that provide maximum access to the spine with minimal soft tissue disruption. MaXcess has a split blade design consisting of three blades that can be positioned to build the surgical exposure in the shape and size specific to the surgical requirements rather than the fixed tube design of other minimally invasive surgical systems. MaXcess’ split blade design also provides expanded access to the spine, which allows surgeons to perform surgical procedures using instruments that are similar to those used in open procedures but with a significantly smaller incision. The ability to use familiar instruments reduces the learning curve and facilitates the adoption of our products. Our system’s illumination of the operative corridor aids in providing surgeons with direct visualization of the patient’s anatomy, without the need for additional technology or other special equipment.

IPSCIO Record ID: 5851

License Grant
The Company entered into a commitment to pay royalties for the use of technology for certain spine-related products to an undisclosed Licensor.
License Property
The Company is engaged in the designing, developing, manufacturing and marketing of implantable devices for minimal invasive surgeries in two primary lines of business, namely spinal conditions and trauma (i.e. bone fractures).
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.